Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
Inloggen

Welkom bij Scalda & Bohn Stafleu van Loghum

Scalda heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen.Je kunt de producten hieronder links aanschaffen en rechts inloggen.

» Andere revante producten voor Scalda studenten en medewerkers.

Registreer

Schaf de BSL Academy aan: 

BSL Academy mbo AG

Eenmaal aangeschaft kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL.

Heb je een vraag, neem dan contact op met Jan van der Velden.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Inloggen
Top
Cognitive Therapy and Research
Gepubliceerd in:

01-04-2008 | Original Paper

Cognitive and Behavioral Mediators of Combined Pharmacotherapy and Psychotherapy of Chronic Depression

Auteurs: Janice A. Blalock, Rachel T. Fouladi, Paul M. Cinciripini, John C. Markowitz, Daniel N. Klein, Barbara O. Rothbaum, Bruce A. Arnow, Rachel Manber, Lawrence P. Riso, Dawen Sui, James P. McCullough Jr

Gepubliceerd in: Cognitive Therapy and Research | Uitgave 2/2008

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

This study examined coping styles and attributions for negative events among chronically depressed outpatients to determine whether these variables mediated differences in depression treatment outcome between combined nefazodone and cognitive behavioral analysis system of psychotherapy (CBASP), versus nefazodone and CBASP alone. Chronically depressed outpatients (N = 517) who completed the initial 12-week treatment phase were included in the analyses. Attributional style and coping met criteria for partial mediation of the combination treatment effect over nefazodone, accounting for 60% of the difference in treatment outcome. Escape-avoidant coping met criteria for partial mediation of the combination treatment effect over CBASP, accounting for 37% of the treatment differential. Among all of the cognitive and coping variables evaluated, escape-avoidance coping emerged as the dominant mediating variable. These findings suggest that nefazodone and CBASP each produced changes in maladaptive cognitions and coping, and that the superiority of combined treatment was partially accounted for by the additive effects of both forms of treatment on these variables.
vorige artikel Moderating effects of sociotropy and autonomy on affective and self-esteem reactivity to daily stressors
volgende artikel Implicit and Explicit Self-Esteem and Attractiveness Beliefs among Individuals with Body Dysmorphic Disorder
Literatuur
Abramson, L. Y., Metalsky, G. I., & Alloy, L. B. (1989). Hopelessness depression: A theory-based subtype of depression. Psychological Review, 96(2), 358–372.CrossRef
Barlow, D. H., Allen, L. B., & Choate, M. L. (2004). Toward a unified treatment for emotional behaviors. Behavior Therapy, 35, 205–230.CrossRef
Baron, R. M., & Kenny, D. A. (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51(6), 1173–1182.PubMedCrossRef
Baxter, L. R., Jr., Clark, E. C., Ackermann, R. F., Lacan, G., & Melega, W. P. (2001). Brain mediation of Anolis social dominance displays. Brain, Behavior and Evolution, 57, 184–201.
Beck, A., Rush, A., Shaw, B., & Emery, C. (1979). Cognitive therapy of depression. New York: Guilford.
Blackburn, I. M., & Bishop, S. (1983). Changes in cognition with pharmacotherapy and cognitive therapy. British Journal of Psychiatry, 143, 609–617.PubMedCrossRef
Brown, R. A., & Lewinsohn, P. M. (1984). A psychoeducational approach to the treatment of depression: Comparison of group, individual, and minimal contact procedures. Journal of Consulting and Clinical Psychology, 52(5), 774–783.PubMedCrossRef
Cronkite, R. C., Moos, R. H., Twohey, J., Cohen, C., & Swindle R., Jr. (1998). Life circumstances and personal resources as predictors of the ten-year course of depression. American Journal of Community Psychology, 26(2), 255–280.
Depression Guideline Panel. (1993). Depression in primary care, Vol 2: Treatment of major depression, clinical practice guideline number 5 (Publication No. 93–0551). Rockville: Agency for Health Care Policy and Research.
DeRubeis, R. J., Evans, M. D., Hollon, S. D., Garvey, M. J., Grove, W. M., & Tuason, V. B. (1990). How does cognitive therapy work? Cognitive change and symptom change in cognitive therapy and pharmacotherapy for depression. Journal of Consulting and Clinical Psychology, 58(6), 862–869.PubMedCrossRef
DeVane, C. L., Grothe, D. R., & Smith, S. L. (2002). Pharmacology of antidepressants: Focus on nefazodone. Journal of Clinical Psychiatry, 63(Suppl. 1), 10–17.PubMed
Edwards, D. H., & Kravitz, E. A. (1997). Serotonin, social status and aggression. Current Opinion in Neurobiology, 7, 812–819.PubMedCrossRef
Eison, A. S., Eison, M. S., Torrente, J. R., Wright, R. N., & Yocca, F. D. (1990). Nefazodone: Preclinical pharmacology of a new antidepressant. Psychopharmacology Bulletin, 26, 311–315.PubMed
Fawcett, J., Epstein, P., Fiester, S. J., Elkin, I., & Autry, J. H. (1987). Clinical management—imipramine/placebo administration manual: NIMH Treatment of Depression Collaboration Research Program. Psychopharmacology Bulletin, 23, 309–324.PubMed
Fawcett, J., Marcus, R. N., Anton, S. F., O’Brien, K., & Schwiderski, U. (1995). Response of anxiety and agitation symptoms during nefazodone treatment of major depression. Journal of Clinical Psychiatry, 56(Suppl. 2), 10–14.
Foa, E. B., & Rothbaum, B. O. (1998). Treating the trauma of rape: A cognitive–behavioral therapy for PTSD. New York: Guilford.
Folkman, S., & Lazarus, R. S. (1988). Ways of Coping Questionnaire: Manual, test booklet, scoring key. Palo Alto: Mind Garden.
Goldapple, K., Segal, Z., Garson, C., Lau, M., Bieling, P., Kennedy, S., et al. (2004). Modulation of cortical–limbic pathways in major depression. Archives of General Psychiatry, 61, 34–41.PubMedCrossRef
Hamilton, M. (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6(4), 278–296.PubMed
Hayes, S. C., Strosahl, K. D., & Wilson, K. G. (1999). Acceptance and commitment therapy: An experiential approach to behavior change. New York: Guilford.
Higley, J. D., King, S. T., Jr., Hasert, M. F., Champoux, M., Suomi, S. J., & Linnoila, M. (1996). Stability of interindividual differences in serotonin function and its relationship to severe aggression and competent social behavior in Rhesus Macaque females. Neuropsychopharmacology, 14(1), 67–76.
Hollon, S. D., & Beck, A. T. (1978). Psychotherapy and drug therapy: Comparisons and combinations. In S. L. Garfield (Eds.), Handbook of psychotherapy and behavior change: An empirical analysis (2nd ed., pp. 437–490). New York: Wiley.
Horst, W. D., & Preskorn, S. H. (1998). Mechanisms of action and clinical characteristics of three atypical antidepressants: Venlafaxine, nefazodone, and bupropion. Journal of Affective Disorders, 51, 237–254.PubMedCrossRef
Howland, R. H. (1993). General health, health care utilization, and medical comorbidity in dysthymia. International Journal of Psychiatry in Medicine, 23(3), 211–238.PubMedCrossRef
Jacobson, N. S., Dobson, K. S., Truax, P. A., Addis, M. E., Koerner, K., Gollan, J. K., et al. (1996). A component analysis of cognitive–behavioral treatment for depression. Journal of Consulting and Clinical Psychology, 64, 295–304.PubMedCrossRef
Jacobson, N. S., Martell, C. R., & Dimidjian, S. (2001). Behavioral activation treatment for depression: Returning to contextual roots. Clinical Psychology: Science and Practice, 8(3), 255–270.CrossRef
Kandel, E. R. (1998). A new intellectual framework for psychiatry. American Journal of Psychiatry, 155(4), 457–469.PubMed
Keller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., et al. (2000). A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. The New England Journal of Medicine, 342, 1462–1470.PubMedCrossRef
Keller, M. B., Shapiro, R. W., Lavori, P. W., & Wolfe, N. (1982). Relapse in major depressive disorder. Archives of General Psychiatry, 39, 911–915.PubMed
Knutson, B., Wolkowitz, O. M., Cole, S. W., Chan, T., Moore, E. A., Johnson, R. C., et al. (1998). Selective alteration of personality and social behavior by serotonergic intervention. American Journal of Psychiatry, 155, 373–379.PubMed
Kraemer, H. C., Wilson, G. T., Fairburn, C. G., & Agras, W. S. (2002). Mediators and moderators of treatment effects in randomized trials. Archives of General Psychiatry, 59, 877–883.PubMedCrossRef
Lewinsohn, P. M. (1974). A behavioral approach to depression. In R. M. Friedman, & M. M. Katz (Eds.), The psychology of depression: Contemporary theory and research. New York: Wiley.
Lewinsohn, P. M., & Arconard, M. (1981). Behavioral treatment of depression: A social learning approach. In J. F. Clarkin, & H. I. Glazer (Eds.), Depression: Behavioral and directive intervention strategies (pp. 33–67). New York: Garland.
Lewinsohn, P. M., & Gotlib, I. H. (1995). Behavioral theory and treatment of depression. In E. E. Becker, & W. R. Leber (Eds.), Handbook of depression (pp. 352–375). New York: Guilford.
Lewinsohn, P. M., & Graf, M. (1973). Pleasant activities and depression. Journal of Consulting and Clinical Psychology, 41, 261–268.PubMedCrossRef
Lynch, T. R., Morse, J. Q., Mendelson, T., & Robins, C. J. (2003). Dialectical behavioral therapy for depressed older adults. American Journal of Geriatric Psychiatry, 11(1), 33–45.PubMedCrossRef
MacKinnon, D. (1994). Analysis of mediating variables in prevention and intervention research. NIDA Research Monograph, 139, 127–153.PubMed
Mayberg, H. S. (1997). Limbic–cortical dysregulation: A proposed model of depression. Journal of Neuropsychiatry, 9, 471–481.
Mayberg, H. S., Silva, J. A., Brannan, S. K., Tekell, J. L., Mahurin, R. K., McGinnis, S., et al. (2002). The functional neuroanatomy of the placebo effect. American Journal of Psychiatry, 159(5), 728–737.PubMedCrossRef
McCullough, J. P. (2000). Treatment for chronic depression: Cognitive behavioral analysis system of psychotherapy. New York: Guilford.
McCullough, J. P., Jr. (2006). Treating chronic depression with disciplined personal involvement. Berlin Heidelberg New York: Springer.
Miller, I. W., Keitner, G. I., Schatzberg, A. F., Klein, D. N., Thase, M. E., Rush, A. J., et al. (1998). The treatment of chronic depression, part 3: Psychosocial functioning before and after treatment with sertraline or imipramine. Journal of Clinical Psychiatry, 59(11), 608–619.PubMed
Moskowitz, D., Pinard, G., Zuroff, D., Annable, L., & Young, S. (2003). Tryptophan, serotonin and human social behavior. Advances in Experimental Medicine and Biology, 527, 215–224.PubMed
Nezu, A. M. (1986). Efficacy of a social problem-solving therapy approach for unipolar depression. Journal of Consulting and Clinical Psychology, 54(2), 196–202.PubMedCrossRef
Nezu, A. M., Nezu, C. M., & Perri, M. G. (1989). Problem-solving therapy for depression: Theory, research, and clinical guidelines. New York: Wiley.
Ninan, P. T., Rush, A. J., Crits-Christoph, P., Kornstein, S. G., Manber, R., Thase, M. E., et al. (2002). Symptomatic and syndromal anxiety in chronic forms of major depression: Effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. Journal of Clinical Psychiatry, 63, 434–441.PubMed
Olfson, M., Marcus, S. C., Druss, B., Elinson, L., Tanielian, T., & Pincus, H. A. (2002). National trends in the outpatient treatment of depression. Journal of American Medical Association, 287(2), 203–209.CrossRef
Otto, M. W., Smits, J. A., & Reese, H. E. (2005). Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: Review and analysis. Clinical Psychology: Science and Practice, 12(1), 72–86.CrossRef
Pampallona, S., Bollini, P., Tibaldi, G., Kupelnick, B., & Munizza, C. (2004). Combined pharmacotherapy and psychological treatment for depression. Archives of General Psychiatry, 61, 714–719.PubMedCrossRef
Peterson, C., Semmel, A., von Baeuer, C., Abramson, L. Y., Metalsky, G. I., & Seligman, M. E. P. (1982). The Attributional Style Questionnaire. Cognitive Therapy and Research, 6(3), 287–300.CrossRef
Raleigh, M. J., McGuire, M. T., Brammer, G. L., Pollack, D. B., & Yuwiler, A. (1991). Serotonergic mechanisms promote dominance acquisition in adult male vervet monkeys. Brain Research, 559(2), 181–190.PubMedCrossRef
Ravindran, A. V., Anisman, H., Merali, Z., Charbonneau, Y., Telner, J., Bialik, R. J., et al. (1999). Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: Clinical symptoms and functional impairments. American Journal of Psychiatry, 156(10), 1608–1617.PubMed
Rush, A. J., Kovacs, M., Beck, A. T., Weissenburger, J., & Hollon, S. D. (1981). Differential effects of cognitive therapy and pharmacotherapy on depressive symptoms. Journal of Affective Disorders, 3, 221–229.PubMedCrossRef
Rush, A. J., & Thase, M. E. (1997). Strategies and tactics in the treatment of chronic depression. Journal of Clinical Psychiatry, 58(Suppl. 13), 14–22.PubMed
Seiffge-Krenke, I., & Klessinger, N. (2000). Long-term effects of avoidant coping on adolescents’ depressive symptoms. Journal of Youth and Adolescence, 29(6), 617–630.CrossRef
Seligman, M. E., Castellon, C., Cacciola, J., Schulman, P., Luborsky, L., Ollove, M., et al. (1988). Explanatory style change during cognitive therapy for unipolar depression. Journal of Abnormal Psychology, 97(1), 13–18.PubMedCrossRef
Shelton, R. C. (2000). Cellular mechanisms in the vulnerability to depression and response to antidepressants. Psychiatric Clinics of North America, 23(4), 713–729.PubMedCrossRef
Simons, A. D., Garfield, S. L., & Murphy, G. E. (1984). The process of change in cognitive therapy and pharmacotherapy for depression. Archives of General Psychiatry, 41, 45–51.PubMed
Thase, M. E., Greenhouse, J. B., Frank, E., Reynolds, C. F., III, Pilkonis, P. A., Hurley, K., et al. (1997). Treatment of major depression with psychotherapy or psychotherapy–pharmacotherapy combinations. Archives of General Psychiatry, 54(11), 1009–1015.
Thase, M. E., Reynolds, C. F., III, Frank, E., Simons, A., Garamoni, G., McGeary, J., et al. (1994). Response to cognitive–behavioral therapy in chronic depression. The Journal of Psychotherapy Practice and Research, 3, 204–214.
Vitaliano, P. P., Maiuro, R. D., Russo, J., & Becker, J. (1987). Raw versus relative scores in the assessment of coping strategies. Journal of Behavioral Medicine, 10(1), 1–18.PubMedCrossRef
Zajecka, J. M. (1996). The effect of nefazodone on comorbid anxiety symptoms associated with depression: Experience in family practice and psychiatric outpatient settings. Journal of Clinical Psychiatry, 57(Suppl. 2), 10–14.PubMed
Metagegevens
Titel
Cognitive and Behavioral Mediators of Combined Pharmacotherapy and Psychotherapy of Chronic Depression
Auteurs
Janice A. Blalock
Rachel T. Fouladi
Paul M. Cinciripini
John C. Markowitz
Daniel N. Klein
Barbara O. Rothbaum
Bruce A. Arnow
Rachel Manber
Lawrence P. Riso
Dawen Sui
James P. McCullough Jr
Publicatiedatum
01-04-2008
Uitgeverij
Springer US
Gepubliceerd in
Cognitive Therapy and Research / Uitgave 2/2008
Print ISSN: 0147-5916
Elektronisch ISSN: 1573-2819
DOI
https://doi.org/10.1007/s10608-006-9092-z

Andere artikelen Uitgave 2/2008

Impact of Priming on Explicit Memory in Spider Fear

  • Original Paper

Hopelessness Theory and the Approach System: Cognitive Vulnerability Predicts Decreases in Goal-Directed Behavior

  • Original Paper

Emotional Abuse, Verbal Victimization, and the Development of Children’s Negative Inferential Styles and Depressive Symptoms

  • Original Article

Predictive Validity of the Children’s Attributional Styles Questionnaire: Linkages with Reactions to an In Vivo Peer Evaluation Manipulation

  • Open Access
  • Original Article

Moderating effects of sociotropy and autonomy on affective and self-esteem reactivity to daily stressors

  • Original Article

Efficacy of a Problem-Solving Therapy for Depression and Suicide Potential in Adolescents and Young Adults

  • Original Article